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Figure S1. ESI/MS spectra for compounds shown in Fig. 2a. a) ESI/MS spectrum of 
aglycone (7). b) ESI/MS spectrum of compound (8). c) ESI/MS spectrum of 
compound (9). 
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Figure S2. Tei-bound Orf2* crystal structure and the structure superimposed with 
Tei-free structure. a) The crystal of the Tei-bound Orf2* structure is packed in a P1 
space group (four polypeptide chains in an asymmetric unit). Tei is presented in grey 
sticks. b) Superimposed structures for native and Tei-bound Orf2*. The native protein 
and the Tei-complexed structure are colored in in gray and green, respectively. 
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Figure S3. Stereo views of BOG-bound structrue. a) Stereo view of overall 
BOG-bound Orf2* structure. b) Stereo view of the 2Fo-Fc electron density map for 
BOG contoured at 1.0 σ (gray mesh).  
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Figure S4. CD spectra of WT and mutants. a) Orf2* (◆), Orf2*+Tei (■). b) H164N 
(◆), H164N+Tei (■). c) H164N-RQ (RQ represents R116A/Q117A double mutation) 
(◆), and H164N-RQ+Tei (■). The CD curves of H164N–RQ in the presence or 
absence of Tei are almost identical, which is similar to those of Orf2* and H164N 
mutant in the presence of Tei. Therefore, the capping loop may be fixed as in a closed 
mode in this double-mutation mutant.  
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Figure S5. Binding affinity of Orf2* mutant (H164N) vs. pseudoaglycone addended 
with a lipid side chain in various lengths. a) ITC thermographs for N-butyrl (C4)-Glc 
Tei-pseudoaglycone, b) ITC thermographs for N-hexyl (C6)-Glc Tei-pseudoaglycone, 
c) ITC thermographs for N-octyl (C8)-Glc Tei-pseudoaglycone d) ITC thermographs 
for N-decanoyl (C10)-Glc Tei-pseudoaglycone. 
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Figure S6. Docking models of r6 GlcNac Tei-bound Orf2*. a) Superpostion of r6 
GlcNac (colored in yellow) with r4 N-acyl Glm (colored in magenta; highlighted by a 
red circle). Tei was rotated 90° in the Tei-bound Orf2* model to superimpose r6 
GlcNac with the r4 N-acyl Glc. First, the remaining part was manually optimized 
from colliding into surrounding residues. Then, the whole structure without the acyl 
side chain was subjected to the CHARMM energy minimization routine. b) A 
considerable collision resulted from the acyl side chain (added back here after the 
energy minimization) with surrounding resiudes as the r4-N-acyl-Glm moiety rotated 
90° (highlighted by a red circle). The r4 N-acyl Glm was considered necessary to 
remove for the deacylation reaction to occur at r6 GlcNac. Based on this re-orientated 
model, residues A120, V121 and F193 were selected and mutated into A120S, V121A 
and F193Y to enhance the deacetylation reaction at r6 HlcNac.  
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Figure S7. ESI/MS spectra for compounds shown in Fig. 2b. a) ESI/MS spectrum of 
aglycone (10). b) ESI/MS spectrum of compound (11).  
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Figure S8. NMR information for compound 7. NMR spectra include 1H, 13C, HSQC, 
HMBC and COSY. 
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Figure S9. NMR information for compound 10. NMR spectra include 1H, 13C, HSQC, 
HMBC and COSY. (a coeluted impurity identified is desiganated as *) 
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Figure S10. NMR information for compound 11. NMR spectra include 1H, 13C, 
HSQC, HMBC and COSY. 
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Table S1 Primer pairs used in the mutagenesis studies 
Name of primer Sequence 
For Orf2* mutant  
R75Q_f (forward) 5'cgacgcggtgctctaccagcggaaagaagac3' 





D97N_f 5’ ggccggttcctcaactccatctaccgtaagttg3’ 





















Q117A_f 5’ ccatgtggagggcagggcgaagctggcc3’ 
Q117A_r 5’ ggccagcttcgccctgccctccacatgg3’ 
R116AQ117A_f 5’ ccatgtggagggcgcggcgaagctggcc3’ 
R116AQ117A_r 5’ ggccagcttcgccgcgccctccacatgg3’ 
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Supplemental Experimental Procedures 
CD analysis 
Far UV CD spectra of wild-type Orf2* and mutants were recorded between 240 and 
190 nm, on a Jasco CD spectropolarimeter at 25°C. Proteins were present at 1 mg 
ml–1 in a standard buffer solution. Each spectrum represents an average of three scans, 
wherein the buffer background is subtracted. 
 
NMR analysis  
NMR analyses were performed on a Bruker Avance 600 spectrometer equipped with 
CryoProbe™, with tetramethylsilane (TMS) as an internal standard. Compounds were 
dissolved in deuterated dimethyl sulfoxide (DMSO-d6) if not otherwise stated, and 
spectra were recorded at room temperature: 
Compound 11. HRMS ES(+): 680.1510 [M+2H]2+, calc. For C64H58Cl2N8O22 680.152 
[M+2H]2+ (SI Figure 20). 1H NMR (600 MHz, DMSO-d6): 9.81 (m, 2H), 9.38 (m, 
1H), 8.67 (m, 1H), 8.30 (m, 3H), 7.84 (m, 4H), 7.67 (m, 2H), 7.48 (m, 1H), 7.19 (m, 
3H), 7.14 (m, 1H), 7.07 (m, 1H), 7.02 (d, J 8.2, 1H), 6.70 (m, 1H), 6.65 (m, 2H), 6.35 
(m, 6H), 5.62 (d, J 8.2, 1H), 5.52 (m, 1H), 5.39 (s, 1H), 5.32 (d, J 10.4, 1H), 5.08 (m, 
1H), 4.98 (m, 1H), 4.91 (m, 1H), 4.33 (m, 4H), 4.14 (m, 1H), 2.99 (m, 4H), 2.87 (m, 
3H), 2.78 (m, 1H), 2.62 (m, 3H), 2.55 (s, 1H), 1.24 (m, 1H). 13C NMR (600 MHz, 
DMSO-d6): 170.08, 169.61, 169.21, 168.29, 166.32, 165.28, 158.62, 157.71, 157.08, 
156.11, 155.50, 150.84, 149.38, 147.93, 147.83, 147.67, 141.95, 140.78, 136.82, 
136.08, 135.53, 134.33, 130.94, 130.61, 129.28, 129.02, 127.91, 127.39, 126.45, 
125.80, 125.74, 125.46, 124.92, 123.28, 121.43, 118.51, 118.27, 117.87, 116.52, 
110.04, 109.58, 107.66, 105.02, 104.49, 103.50, 102.19, 77.59, 75.01, 73.46, 72.56, 
69.91, 63.05, 60.93, 60.44, 59.57, 58.14, 56.55, 56.40, 54.81, 54.77, 53.56, 41.10, 
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40.42, 36.39. An expanded version of HSQC, HMBC and 1H COSY spectra of the 
deacetylated compound 11 is shown in SI Figure 10. 
Compound 10. HRMS ES(+): 712.1442 [M+H+Na]2+, calc. for C66H59Cl2N8O23Na 
712.1484 [M+H+Na]2+ (SI Figure 20). 1H NMR (600 MHz, DMSO-d6): 9.75 (s, 1H), 
9.52 (m, 1H), 9.34 (s, 1H), 8.52 (m, 1H), 8.29 (m, 1H), 7.88 (m, 2H), 7.75 (m, 1H), 
7.69 (m, 1H), 7.62 (m, 2H), 7.52 (m, 1H), 7.24 (m, 4H), 7.14 (m, 1H), 7.05 (s, 1H), 
6.95 (d, J 8.3, 1H), 6.68 (m, 1H), 6.63 (m, 1H), 6.59 (m, 1H), 6.34 (m, 5H), 6.10 (d, J 
11.5, 1H), 5.65 (d, J 8.1, 1H), 5.51 (m, 1H), 5.34 (m, 1H), 5.29 (m, 1H), 5.06 (m, 2H), 
4.95 (m, 1H), 4.87 (m, 1H), 4.68 (s, 1H), 4.37 (d, J 6.1, 1H), 4.33 (d, J 7.3, 1H), 4.27 
(m, 1H), 4.13 (m, 1H), 3.66 (m, 2H), 3.10 (m, 2H), 3.04 (m, 2H), 2.98 (m, 1H), 2.82 
(m, 1H), 1.85 (s, 3H), 1.22 (m, 1H), 0.82 (m, 1H). 13C NMR (600 MHz, DMSO-d6): 
173.23, 170.45, 169.72, 169.27, 169.12, 168.24, 167.03, 166.22, 158.57, 157.55, 
157.07, 156.23, 155.59, 150.76, 149.28, 147.76, 147.60, 147.41, 141.75, 140.87, 
138.43, 135.80, 135.61, 134.28, 131.76, 131.67, 130.97, 130.37, 128.76, 128.68, 
127.90, 127.53, 126.66, 125.65, 125.57, 125.50, 124.91, 123.43, 121.67, 118.47, 
117.82, 116.54, 114.59, 110.09, 104.99, 104.48, 103.37, 102.15, 98.92, 76.90, 75.74, 
73.23, 70.60, 61.06, 60.97, 58.09, 57.31, 56.13, 54.77, 54.62, 53.80, 36.58, 23.19. An 
expanded version of HSQC, HMBC and 1H COSY spectra of the compound 10 is 
shown in SI Figure 9.  
Compound 7. HRMS ES(+): 1220.2099 [M+Na]+, calc. for C58H45Cl2N7O18Na 
1220.2096 [M+Na]+ (SI Figure 20). 1H NMR (600 MHz, DMSO-d6): 9.38 (m, 2H), 
8.45 (m, 1H), 8.29 (m, 1H), 7.79 (s, 1H), 7.67 (m, 2H), 7.45 (m, 1H), 7.24 (m, 2H), 
7.10 (m, 2H), 6.94 (d, J 8.3, 1H), 6.69 (m, 3H), 6.34 (m, 4H), 5.65 (d, J 8.2, 1H), 5.49 
(m, 1H), 5.32 (d, J 10.6, 1H), 5.10 (m, 2H), 4.96 (m, 1H), 4.62 (s, 1H), 4.37 (m, 11H), 
4.11 (d, J 11.8, 1H), 2.84 (m, 1H), 1.24 (m, 1H). 13C NMR (600 MHz, DMSO-d6): 
170.27, 169.21, 169.07, 168.12, 167.44, 158.52, 157.31, 157.13, 156.38, 155.51, 
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150.60, 148.58, 147.56, 147.43, 146.93, 142.25, 141.40, 140.83, 135.66, 135.54, 
134.15, 130.91, 130.23, 127.69, 127.57, 127.28, 126.15, 125.82, 125.65, 125.06, 
124.80, 123.23, 121.25, 118.35, 117.74, 117.50, 116.44, 110.03, 107.04, 104.87, 
104.27, 103.10, 102.34, 72.49, 71.56, 63.07, 61.70, 61.02, 60.47, 59.73, 58.01, 57.86, 
54.72, 54.28, 53.62, 36.67. An expanded version of HSQC, HMBC and 1H COSY 
spectra of the compound 5 is shown in SI Figure 8.  
 
 
